Sign inJoin waitlistJoin the waitlist

Mark Kupersmith

Director · North American Neuro-Ophthalmology Research Disease Investigator Consortium

Credentials: · · · ·

History

Union Square Eye Center LLC
2025–Present

Neurology
New York University
1978–1982
Ophthalmology
New York University
1975–1978
Preliminary or Transitional Year
1974–1975
Feinberg School of Medicine
1970–1974

Research

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group
New England Journal of Medicine · 1992 · 970 citations
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group
New England Journal of Medicine · 1993 · 439 citations
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial
JAMA · 2014 · Last of 11 authors · 414 citations

Alejandro Berenstein
31 papers
Randy Kardon
27 papers
Michael Wall
26 papers
AL
Abraham Lieberman
21 papers
FW
Floyd Warren
16 papers
Neil Miller
16 papers
PS
Patrick Sibony
15 papers
RC
Ronald Carr
13 papers
AN
Andreas Neophytides
10 papers
John Keltner
10 papers
LF
Larry Frohman
10 papers · 2 as a resident
Steven Feldon
10 papers

Grants

Statistical Unsupervised Learning VF for IIHTT & ONTT
National Eye Institute · R21
Contact PI · $495.3K · Icahn School of Medicine at Mount Sinai
2021–2024
Surgical IIH Treatment Trial
National Eye Institute · U10
Contact PI · $7.9M · Icahn School of Medicine at Mount Sinai
2017–2022
Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) Network
National Eye Institute · U10
Contact PI · $10.2M · St. Luke's-Roosevelt Inst for Hlth Scis
2009–2016
Prednisone Ocular Myasthenia Gravis Trial Planning Grant
National Institute of Neurological Disorders and Stroke · R34
Contact PI · $203.6K · Beth Israel Medical Ctr (New York)
2004–2006

Clinical trials

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Principal investigator · Completed · Phase 3
Teva Branded Pharmaceutical Products R&D, Inc.
2009–2011

Honors

ARVO Silver Fellows Award
2020
Association for Research and Vision in Ophthalmology (ARVO)